Pacira BioSciences' Inventory Average rose 4205.24% to $152.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.9 million, marking a year-over-year increase of 4205.24%. This contributed to the annual value of $114.8 million for FY2024, which is 1457.92% up from last year.
Latest data reveals that Pacira BioSciences reported Inventory Average of $152.9 million as of Q3 2025, which was up 4205.24% from $141.0 million recorded in Q2 2025.
Pacira BioSciences' Inventory Average's 5-year high stood at $152.9 million during Q3 2025, with a 5-year trough of $64.6 million in Q1 2021.
For the 5-year period, Pacira BioSciences' Inventory Average averaged around $100.5 million, with its median value being $100.1 million (2024).
Per our database at Business Quant, Pacira BioSciences' Inventory Average skyrocketed by 5727.27% in 2022 and then plummeted by 937.23% in 2023.
Pacira BioSciences' Inventory Average (Quarter) stood at $82.9 million in 2021, then increased by 16.35% to $96.4 million in 2022, then increased by 4.15% to $100.4 million in 2023, then grew by 18.06% to $118.6 million in 2024, then increased by 28.97% to $152.9 million in 2025.
Its Inventory Average was $152.9 million in Q3 2025, compared to $141.0 million in Q2 2025 and $129.5 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value